Literature DB >> 22349898

[Multiparametric prostate MRI for follow-up monitoring after radiation therapy].

A M Weidner1, D J Dinter, M Bohrer, M Sertdemir, D Hausmann, F Wenz, S O Schoenberg.   

Abstract

CLINICAL/METHODICAL ISSUE: Radiation therapy is a therapeutic option with curative intent for patients with prostate cancer. Monitoring of prostate-specific antigen (PSA) values is the current standard of care in the follow-up. Imaging is recommended only for symptomatic patients and/or for further therapeutic options. STANDARD RADIOLOGICAL
METHODS: For detection of local recurrence magnetic resonance imaging (MRI) of the prostate is acknowledged as the method of choice. PERFORMANCE: Good results for primary diagnosis were found especially in combination with functional techniques, whereas in recurrent prostate cancer only few studies with heterogeneous study design are available for prostate MRI. Furthermore, changes in different MRI modalities due to radiation therapy have been insufficiently investigated to date. PRACTICAL RECOMMENDATIONS: As the initial results were promising prostate MRI and available therapeutic options for detection of local recurrence should be considered in patients with increased PSA.

Entities:  

Mesh:

Year:  2012        PMID: 22349898     DOI: 10.1007/s00117-011-2196-9

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  39 in total

1.  Inverse planning for HDR prostate brachytherapy used to boost dominant intraprostatic lesions defined by magnetic resonance spectroscopy imaging.

Authors:  Jean Pouliot; Yongbok Kim; Etienne Lessard; I-Chow Hsu; Daniel B Vigneron; John Kurhanewicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-15       Impact factor: 7.038

2.  The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings.

Authors:  Taylan Kara; Deniz Akata; Fadıl Akyol; Muşturay Karçaaltıncaba; Mustafa Özmen
Journal:  Diagn Interv Radiol       Date:  2010-08-12       Impact factor: 2.630

Review 3.  Role of MRI in follow-up after focal therapy for prostate carcinoma.

Authors:  Pieter J De Visschere; Gert O De Meerleer; Jurgen J Fütterer; Geert M Villeirs
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

4.  Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer?

Authors:  Yasushi Itou; Katsuyuki Nakanishi; Yoshifumi Narumi; Yasuko Nishizawa; Hideaki Tsukuma
Journal:  J Magn Reson Imaging       Date:  2011-01       Impact factor: 4.813

5.  Ferumoxtran-10 MR lymphography for target definition and follow-up in a patient undergoing image-guided, dose-escalated radiotherapy of lymph nodes upon PSA relapse.

Authors:  Anja M Weidner; Emile N J Th van Lin; Dietmar J Dinter; Tom Rozema; Stefan O Schoenberg; Frederik Wenz; Jelle O Barentsz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2011-02-21       Impact factor: 3.621

6.  Prostate cancer: correlation of MR imaging and MR spectroscopy with pathologic findings after radiation therapy-initial experience.

Authors:  Darko Pucar; Amita Shukla-Dave; Hedvig Hricak; Chaya S Moskowitz; Kentaro Kuroiwa; Semra Olgac; Lanie E Ebora; Peter T Scardino; Jason A Koutcher; Kristen L Zakian
Journal:  Radiology       Date:  2005-06-21       Impact factor: 11.105

7.  Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy.

Authors:  Tim Joseph; David A McKenna; Antonio C Westphalen; Fergus V Coakley; Shoujun Zhao; Ying Lu; I-Chow Hsu; Mack Roach; John Kurhanewicz
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-28       Impact factor: 7.038

8.  T2-Weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy.

Authors:  Antonio C Westphalen; John Kurhanewicz; Rui M G Cunha; I-Chow Hsu; John Kornak; Shoujun Zhao; Fergus V Coakley
Journal:  Int Braz J Urol       Date:  2009 Mar-Apr       Impact factor: 1.541

9.  Time to metabolic atrophy after permanent prostate seed implantation based on magnetic resonance spectroscopic imaging.

Authors:  Barby Pickett; Randall K Ten Haken; John Kurhanewicz; Aliya Qayyum; Katsuto Shinohara; Beverly Fein; Mack Roach
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-07-01       Impact factor: 7.038

10.  MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.

Authors:  Tobias Franiel; Lutz Lüdemann; Matthias Taupitz; Dirk Böhmer; Dirk Beyersdorff
Journal:  Radiother Oncol       Date:  2009-09-10       Impact factor: 6.280

View more
  1 in total

1.  Radiomics of Multiparametric MRI to Predict Biochemical Recurrence of Localized Prostate Cancer After Radiation Therapy.

Authors:  Qiu-Zi Zhong; Liu-Hua Long; An Liu; Chun-Mei Li; Xia Xiu; Xiu-Yu Hou; Qin-Hong Wu; Hong Gao; Yong-Gang Xu; Ting Zhao; Dan Wang; Hai-Lei Lin; Xiang-Yan Sha; Wei-Hu Wang; Min Chen; Gao-Feng Li
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.